Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke. - Wikidata - wikimedia - TriplyDB

Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke.

Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke.

http://www.wikidata.org/entity/Q34087922

about

Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene Genetic susceptibility to ischemic stroke.Stroke and Fabry disease.Lombardia GENS: a collaborative registry for monogenic diseases associated with stroke.Genetics of ischemic stroke in young adults.New information on the genetics of stroke.Update on role of agalsidase alfa in management of Fabry disease.Fabry disease and early stroke Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke.Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia.Fabry disease: incidence of the common later-onset α-galactosidase A IVS4+919G→A mutation in Taiwanese newborns--superiority of DNA-based to enzyme-based newborn screening for common mutations Homocysteine and erythrocyte sedimentation rate correlate with cerebrovascular disease in fabry disease.Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease.Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma.Descriptive epidemiology of Fabry disease among beneficiaries of the Specified Disease Treatment Research Program in Japan.Fabry disease: a review of current management strategies.Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy.Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.Angiotensinogen promoter and angiotensinogen II receptor type 1 gene polymorphisms and incidence of ischemic stroke and neurologic phenotype in Fabry disease.Difficulties and barriers in diagnosing Fabry disease: what can be learnt from the literature?Risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS).Early diagnosis of fabry disease in a patient with toe tip pain.p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males.Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients.A Diagnostic Approach to Stroke in Young Adults.Fabry disease and Factor V Leiden: a potent vascular risk combination.Therapeutic goals in the treatment of Fabry disease.Fabry disease in unselected patients with TIA or stroke: population-based study.Fabry disease

P2860

Q28485955-A7506BD6-9200-4D23-A06F-9B7173B57ACC Q30414709-D94720DD-2E9F-4D91-ABAD-DA07BF980AFD Q34061632-0D93126D-A72F-45C4-AF98-5477DFEF68CF Q34480067-12AB9DDE-9521-4761-ACFB-E4158DD22D93 Q34510621-AB0D3C7D-4770-4405-9734-419DDD6782A1 Q34664010-C4935C1A-0715-4E2F-9F46-06DB62C11C29 Q34883178-6D02D51E-FA7A-4333-998F-276EEC24722E Q35110216-9315CA14-D355-44C3-BAEB-8B5332CD2291 Q35754682-2EE69857-A11A-44D7-A9B5-D122FAEDEDED Q35865045-DBA20BA5-25A4-4306-B7C4-260871C50126 Q36130925-E3BB383D-FB22-4947-95FE-10CAD8FA2E74 Q36590911-B3315698-5219-4F56-984B-3A0AD52A0F93 Q36611898-B0317B3A-4D7A-4795-8EE4-6F07B89B59C3 Q36691965-260DA127-92E4-49FE-8C13-4F7B9F1E8A51 Q37234539-69BD25D9-BF5B-445F-8FA1-2714CFD5036B Q37775790-8CD0E1D7-FFA9-4EFF-B09A-F1BD7D5D37EC Q37994740-E047A971-772C-477A-9FB8-3435BEB4376D Q37997470-7D7334A7-6362-4D20-99FC-9A99577586C9 Q38127171-CDA05B0D-105A-492F-A26A-01EB7DD9233C Q38135874-E9D196A2-2C28-47DA-8C75-72471D43619F Q38152826-27A0BBF9-6BDD-4AA7-944A-2EB5E87FFFF3 Q40843747-685BEF19-5C20-4EC5-86A9-5D7E0A1E78B4 Q42429589-8DC806B4-E8E9-4DEE-8260-1B361CB6664A Q45236280-C9B01938-4BB0-4E75-8C27-1B2925CC796E Q47648317-8C822614-D8CB-464A-86AB-FCD380ACA56A Q47835191-97BBC652-74C3-43A8-A678-BB2886AD7256 Q48096636-0834E12A-8BD7-47BD-A47C-24FFEC8D1A25 Q48664517-BBA6C127-102A-42D9-B364-1ACBFB678909 Q50436079-0F1E4F2C-23E5-4889-AAFC-B062D00DB671 Q54312694-0D364A31-9330-4055-BC57-9B8CAF1E2EB4 Q56905945-843F0C31-A463-484D-B932-622B58E37E90

P2860

Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke.

http://www.wikidata.org/entity/Q34087922

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@ast

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@en

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@nl

type

label

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@ast

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@en

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@nl

prefLabel

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@ast

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@en

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@nl

P1433

Q34087922-CC2744DE-A0F7-4594-B08A-FBB1683AE9AC

P1476

Q34087922-2C241B69-888C-4F60-85FE-4746D3BDA593

P2093

Q34087922-0206D4DB-B229-4C4C-AF9A-08A61075F3A0

Q34087922-05118E1C-23F5-45E7-AA1F-EC3A460D8572

Q34087922-1F2BE394-672A-4A39-9C3D-773A4B2EDCCD

Q34087922-344369CC-EEF3-4769-9271-23A1E231144F

Q34087922-44C075E1-9F45-4545-B76B-A8AA71923C4E

Q34087922-744B20EC-D877-413A-8692-9E9D00AB0973

Q34087922-7E3218D1-9A11-4596-9C75-F7C05D8C2A86

Q34087922-7FA04974-3A8A-4215-BB1C-5EFFBA85F853

Q34087922-84BD9590-3AA3-45BB-9A02-943358994C10

Q34087922-8C3F5DE4-DC36-49E8-8582-9AAF95F336C6

P2860

Q34087922-0465A634-B389-413C-959D-75482B6EB692

Q34087922-048E75AF-0946-44A0-AD47-8A00E98A289A

Q34087922-05052F7C-CC9F-4BD3-8829-62EF1FB3E656

Q34087922-1CF8F81D-F609-44B3-8B89-34C02CB7FEAE

Q34087922-23929408-8E1B-466E-B723-73A7E7B86404

Q34087922-244A0CF7-A8F0-4E40-B73E-F37C7E5FD1E7

Q34087922-28DFE4D1-07C1-4656-B13D-7A620DE86C5C

Q34087922-4BF0DDD1-A9DA-41A1-A880-3F3D863BDA6D

Q34087922-72978A90-A06B-483A-9228-8201A40A15B9

Q34087922-BAD12E0A-F084-4358-9C3E-56A2D9C2CA22

P304

Q34087922-C189DF12-6758-42D1-B1B9-34B526180CFE

P31

Q34087922-F91CA55A-9122-4CA8-8445-1306C9F6C18E

P356

Q34087922-A4E0A022-85FC-4EFB-A581-146FEF5ED524

P407

Q34087922-BAAD42C1-FEDB-40EA-92D1-F966B8E7C3FC

P433

Q34087922-1FA62CD8-E389-4D2D-970E-6291AB1D9A07

P478

Q34087922-376D64C9-EA16-4429-A708-B39E114C84CA

P577

Q34087922-FD48AEE2-E196-4A02-B89F-AF33EEE8539B

P698

Q34087922-5B9C4B2E-3ED8-4703-9B20-B116A652733A

P932

Q34087922-6947A562-AD39-4683-AF43-E3A44C1387F3

P356

STROKEAHA.109.558320

P1433

P1476

Frequency of unrecognized Fabr ...... en with first ischemic stroke.

@en

P2093

Barney Stern

http://www.w3.org/2001/XMLSchema#string

Eric McDade

http://www.w3.org/2001/XMLSchema#string

Irina Nazarenko

http://www.w3.org/2001/XMLSchema#string

John W Cole

http://www.w3.org/2001/XMLSchema#string

Marcella A Wozniak

http://www.w3.org/2001/XMLSchema#string

Marie E Grace

http://www.w3.org/2001/XMLSchema#string

Mark Dobbins

http://www.w3.org/2001/XMLSchema#string

Robert Dobrovolny

http://www.w3.org/2001/XMLSchema#string

Robert J Desnick

http://www.w3.org/2001/XMLSchema#string

Stanley Tuhrim

http://www.w3.org/2001/XMLSchema#string

P2860

An atypical variant of Fabry's disease with manifestations confined to the myocardium

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

High incidence of later-onset fabry disease revealed by newborn screening

Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations.

Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.

Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy.

Significance of screening for Fabry disease among male dialysis patients.

Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke.

Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life.

P304

78-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.109.558320

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20007919

http://www.w3.org/2001/XMLSchema#string

P932

3564050

http://www.w3.org/2001/XMLSchema#string